- 米国企業
- Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc.RPHM
時価総額
$6062.7万
PER
2021年 12月31日 | 2022年 12月31日 | |
Research and development | 28 | 38 |
General and administrative | 12 | 16 |
Total operating expenses | 40 | 54 |
Loss from operations | -40 | -54 |
Other income | - | 2 |
Net loss | -40 | -52 |
Unrealized (loss) gain on short-term investments | 0 | -0 |
Comprehensive loss | -40 | -52 |
Earnings Per Share, Basic | -2.19 | -2.12 |
Earnings Per Share, Diluted | -2.19 | -2.12 |